On the Money: F&P Healthcare, Westpac, Fletcher, Rob Campbell and more

On the Money: F&P Healthcare, Westpac, Fletcher, Rob Campbell and more
Fisher & Paykel boss Lewis Gradon avoided guidance at this week's analyst briefing.
Victoria Young
Welcome to On the Money, our weekly column on money and the people making it. Spin cycleAfter dishing up a stellar 82% jump in net profit for the year ended March, Fisher & Paykel Healthcare boss Lewis Gradon told analysts he wasn't able to guide them on what to expect this financial year.The state of the market has been so complicated by the covid-19-inspired unprecedented demand for his company's devices, which aid breathing, he explained.Analysts were clearly frustrated about this, possibly stung by the f...

More Editor's Picks

Why Savor Group won't sell you lamb cutlets
Markets Small Cap Wrap

Why Savor Group won't sell you lamb cutlets

Plus, its D-day for Tait's Vital takeover, and more.

Expressway bidder faces scrutiny amid Sydney rail allegations
Infrastructure

Expressway bidder faces scrutiny amid Sydney rail allegations

NZTA is monitoring the situation as it assesses a local bid involving Webuild.

Oliver Lewis 11 Sep 2025
ANZ's NZ operation may escape worst of 'Nuno-geddon'
Finance

ANZ's NZ operation may escape worst of 'Nuno-geddon'

ANZ NZ’s performance might be its potential saving grace.

Andy Macdonald 10 Sep 2025
Tariffs tanked markets – NZ Super Fund cashed in
Markets

Tariffs tanked markets – NZ Super Fund cashed in

The Super Fund netted $745 million from active investments. How?